US Stock MarketDetailed Quotes

UNCY Unicycive Therapeutics

Watchlist

0.3090
+0.0090+3.00%

Close Aug 16 16:00 ET

0.3015
-0.0075-2.43%

Post 19:53 ET

29.16MMarket Cap-858P/E (TTM)

Unicycive Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Total revenue

-29.02%675K

675K

951K

Operating revenue

--0

-29.02%675K

--0

--675K

--951K

--0

--951K

Cost of revenue

Gross profit

Operating expense

71.24%7.4M

88.72%9.2M

12.87%21.45M

18.55%6.31M

-8.72%5.94M

18.87%4.32M

37.89%4.88M

111.69%19M

93.50%5.33M

37.96%6.51M

Selling and administrative expenses

23.26%2.53M

29.45%2.39M

30.15%8.55M

40.07%2.08M

50.76%2.57M

15.71%2.06M

15.15%1.85M

126.68%6.57M

6.76%1.49M

81.26%1.7M

-General and administrative expense

23.26%2.53M

29.45%2.39M

30.15%8.55M

40.07%2.08M

50.76%2.57M

15.71%2.06M

15.15%1.85M

126.68%6.57M

6.76%1.49M

81.26%1.7M

Research and development costs

114.73%4.87M

124.85%6.81M

3.75%12.9M

10.23%4.23M

-29.79%3.37M

21.88%2.27M

56.75%3.03M

104.54%12.44M

182.15%3.84M

27.20%4.8M

Operating profit

-71.24%-7.4M

-119.04%-9.2M

-15.08%-20.77M

-18.55%-6.31M

-6.91%-5.94M

-18.87%-4.32M

-18.80%-4.2M

-101.09%-18.05M

-93.50%-5.33M

-17.79%-5.55M

Net non-operating interest income expense

120.79%446K

2,350.00%49K

8,983.33%533K

4,133.33%121K

7,066.67%209K

202K

99.04%-6K

-3K

94.55%-3K

Non-operating interest income

97.44%462K

392.86%69K

--615K

--140K

--227K

--234K

--14K

--0

Non-operating interest expense

-50.00%16K

66.67%20K

1,266.67%82K

533.33%19K

500.00%18K

--32K

--12K

-99.04%6K

--3K

-94.55%3K

Other net income (expense)

5,860.99%16.81M

-13.81%-11.81M

-10.3M

-1.61M

1.4M

282K

-10.38M

Gain on sale of security

5,860.99%16.81M

-13.81%-11.81M

---10.3M

---1.61M

--1.4M

--282K

---10.38M

----

Income before tax

356.77%9.86M

-43.83%-20.96M

-69.14%-30.54M

-46.36%-7.8M

22.03%-4.33M

-5.56%-3.84M

-312.07%-14.58M

-80.27%-18.06M

-93.60%-5.33M

-6.84%-5.56M

Income tax

Net income

356.77%9.86M

-43.83%-20.96M

-69.14%-30.54M

-46.36%-7.8M

22.03%-4.33M

-5.56%-3.84M

-312.07%-14.58M

-80.27%-18.06M

-93.60%-5.33M

-6.84%-5.56M

Net income continuous Operations

356.77%9.86M

-43.83%-20.96M

-69.14%-30.54M

-46.36%-7.8M

22.03%-4.33M

-5.56%-3.84M

-312.07%-14.58M

-80.27%-18.06M

-93.60%-5.33M

-6.84%-5.56M

Minority interest income

Net income attributable to the parent company

356.77%9.86M

-43.83%-20.96M

-69.14%-30.54M

-46.36%-7.8M

22.03%-4.33M

-5.56%-3.84M

-312.07%-14.58M

-80.27%-18.06M

-93.60%-5.33M

-6.84%-5.56M

Preferred stock dividends

47.10%887K

8.33%208K

867K

72K

603K

192K

Other preferred stock dividends

5.93M

Net income attributable to common stockholders

168.52%3.04M

-43.37%-21.17M

-73.95%-31.41M

-46.36%-7.8M

20.73%-4.41M

-22.14%-4.44M

-317.50%-14.77M

-80.27%-18.06M

-93.60%-5.33M

-6.84%-5.56M

Basic earnings per share

127.59%0.08

37.11%-0.61

-6.67%-1.28

54.29%-0.16

64.86%-0.13

-20.83%-0.29

-304.17%-0.97

-39.53%-1.2

-105.88%-0.35

0.00%-0.37

Diluted earnings per share

48.28%-0.15

37.11%-0.61

-6.67%-1.28

54.29%-0.16

64.86%-0.13

-20.83%-0.29

-304.17%-0.97

-39.53%-1.2

-105.88%-0.35

0.00%-0.37

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Total revenue	0	0	-29.02%675K	0	0	0	675K	951K	0	951K
Operating revenue	--0	--0	-29.02%675K	--0	--0	--0	--675K	--951K	--0	--951K
Cost of revenue
Gross profit
Operating expense	71.24%7.4M	88.72%9.2M	12.87%21.45M	18.55%6.31M	-8.72%5.94M	18.87%4.32M	37.89%4.88M	111.69%19M	93.50%5.33M	37.96%6.51M
Selling and administrative expenses	23.26%2.53M	29.45%2.39M	30.15%8.55M	40.07%2.08M	50.76%2.57M	15.71%2.06M	15.15%1.85M	126.68%6.57M	6.76%1.49M	81.26%1.7M
-General and administrative expense	23.26%2.53M	29.45%2.39M	30.15%8.55M	40.07%2.08M	50.76%2.57M	15.71%2.06M	15.15%1.85M	126.68%6.57M	6.76%1.49M	81.26%1.7M
Research and development costs	114.73%4.87M	124.85%6.81M	3.75%12.9M	10.23%4.23M	-29.79%3.37M	21.88%2.27M	56.75%3.03M	104.54%12.44M	182.15%3.84M	27.20%4.8M
Operating profit	-71.24%-7.4M	-119.04%-9.2M	-15.08%-20.77M	-18.55%-6.31M	-6.91%-5.94M	-18.87%-4.32M	-18.80%-4.2M	-101.09%-18.05M	-93.50%-5.33M	-17.79%-5.55M
Net non-operating interest income expense	120.79%446K	2,350.00%49K	8,983.33%533K	4,133.33%121K	7,066.67%209K	202K	2K	99.04%-6K	-3K	94.55%-3K
Non-operating interest income	97.44%462K	392.86%69K	--615K	--140K	--227K	--234K	--14K	--0	--0	--0
Non-operating interest expense	-50.00%16K	66.67%20K	1,266.67%82K	533.33%19K	500.00%18K	--32K	--12K	-99.04%6K	--3K	-94.55%3K
Other net income (expense)	5,860.99%16.81M	-13.81%-11.81M	-10.3M	-1.61M	1.4M	282K	-10.38M
Gain on sale of security	5,860.99%16.81M	-13.81%-11.81M	---10.3M	---1.61M	--1.4M	--282K	---10.38M	----	----	----
Income before tax	356.77%9.86M	-43.83%-20.96M	-69.14%-30.54M	-46.36%-7.8M	22.03%-4.33M	-5.56%-3.84M	-312.07%-14.58M	-80.27%-18.06M	-93.60%-5.33M	-6.84%-5.56M
Income tax
Net income	356.77%9.86M	-43.83%-20.96M	-69.14%-30.54M	-46.36%-7.8M	22.03%-4.33M	-5.56%-3.84M	-312.07%-14.58M	-80.27%-18.06M	-93.60%-5.33M	-6.84%-5.56M
Net income continuous Operations	356.77%9.86M	-43.83%-20.96M	-69.14%-30.54M	-46.36%-7.8M	22.03%-4.33M	-5.56%-3.84M	-312.07%-14.58M	-80.27%-18.06M	-93.60%-5.33M	-6.84%-5.56M
Minority interest income
Net income attributable to the parent company	356.77%9.86M	-43.83%-20.96M	-69.14%-30.54M	-46.36%-7.8M	22.03%-4.33M	-5.56%-3.84M	-312.07%-14.58M	-80.27%-18.06M	-93.60%-5.33M	-6.84%-5.56M
Preferred stock dividends	47.10%887K	8.33%208K	867K	0	72K	603K	192K
Other preferred stock dividends	5.93M					0
Net income attributable to common stockholders	168.52%3.04M	-43.37%-21.17M	-73.95%-31.41M	-46.36%-7.8M	20.73%-4.41M	-22.14%-4.44M	-317.50%-14.77M	-80.27%-18.06M	-93.60%-5.33M	-6.84%-5.56M
Basic earnings per share	127.59%0.08	37.11%-0.61	-6.67%-1.28	54.29%-0.16	64.86%-0.13	-20.83%-0.29	-304.17%-0.97	-39.53%-1.2	-105.88%-0.35	0.00%-0.37
Diluted earnings per share	48.28%-0.15	37.11%-0.61	-6.67%-1.28	54.29%-0.16	64.86%-0.13	-20.83%-0.29	-304.17%-0.97	-39.53%-1.2	-105.88%-0.35	0.00%-0.37
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall